FRLI (Frelii) Beta: 108.9000 (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Frelii Beta?

Frelii FRLI -99.00% Beta is 108.9000 as of Aug. 08, 2026.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-08), Frelii's Beta is 108.9000.

Frelii  (OTCPK:FRLI) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)

Frelii Beta Related Terms

Frelii Beta Historical Data

* Premium members only.

The historical data trend for Frelii's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frelii Beta Chart

Frelii Annual Data
Trend May09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.37 -24.78 -19.47 -30.31 16.63

Frelii Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.13 16.63 12.86 10.56 11.17

FRLI vs ESSI, CRVW, VYND: Beta Comparison

For the Health Information Services subindustry, Frelii's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frelii Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Frelii's Beta distribution charts can be found below:

* The bar in red indicates where Frelii's Beta falls into.


Frelii Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 108.9000 mean?
Frelii (FRLI) has a Beta of 108.9000 as of Aug. 08, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Frelii and its competitors.
Is Frelii's Beta too high?
Frelii's current Beta is 108.9000.
How does Frelii's Beta compare to ESSI and CRVW?
Frelii's Beta of 108.9000 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Frelii and its competitors. Frelii's current Beta is 108.9000. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frelii stock overvalued right now?
Frelii (FRLI) has a current Beta of 108.9000. The current Beta is 108.9000. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Frelii (FRLI), the current Beta is 108.9000 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Frelii Business Description

Address 2701 North Thanksgiving Way, Suite 100, Lehi, UT, USA, 84043
Frelii Inc is a United States-based company engaged in offering web-based subscription service providing personalized nutrition and wellness plans on user's genetic data. It provides an artificial intelligence-based algorithm which generates accurate and valuable insight about individual health risks. The company's algorithm, through a web-based questionnaire, and upload of the user's raw genetic data identifies areas of potential health risk and generates a preventative action plan. The plan includes a personalized nutrition and fitness plan, and nutritional supplement recommendations. In addition, the company also offers nutritional and vitamin supplements. Its product portfolio includes KDIR, BLDB tonic, Keotone-Cocoa, CTV, and others.